GCS
MRK icon

Gordian Capital (Singapore)’s Merck MRK Stock Holding History

Gordian Capital (Singapore)’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,000
Closed -$526K – 160
2025
Q4 		$526K Buy
+5,000
New +$469K 0.73% 40
2022
Q2 		– Sell
-2,000
Closed -$163K – 141
2022
Q1 		$163K Hold
2,000
– – 0.13% 52
2021
Q4 		$154K Buy
+2,000
New +$159K 0.12% 67

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Gordian Capital (Singapore)'s MRK Position: Q1 2026 in Review

Gordian Capital (Singapore) sold out of Merck (MRK) in Q1 2026, closing a stake of 5,000 shares — an estimated $526K sold.

Gordian Capital (Singapore) first reported a position in MRK in Q4 2021 and held it in 3 quarters. The position peaked at $526K in Q4 2025. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Gordian Capital (Singapore) reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
  • Gordian Capital (Singapore) sold 5,000 Merck shares in Q1 2026, an estimated $526K.
  • Gordian Capital (Singapore) first reported a position in Merck in Q4 2021 and held it in 3 quarters.
  • Gordian Capital (Singapore)'s Merck position peaked at $526K in Q4 2025.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Gordian Capital (Singapore)'s 13F filing for Q1 2026, filed 13 May 2026.